CastleKeep Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Sell
11,496
-831
-7% -$72.7K 0.53% 40
2026
Q1
$1.05M Sell
12,327
-67
-0.5% -$5.97K 0.57% 49
2025
Q4
$979K Buy
12,394
+1,199
+11% +$94K 0.44% 64
2025
Q3
$895K Sell
11,195
-1,526
-12% -$130K 0.42% 72
2025
Q2
$1.16M Sell
12,721
-893
-7% -$81.5K 0.57% 67
2025
Q1
$1.28M Buy
13,614
+94
+0.7% +$8.42K 0.66% 52
2024
Q4
$1.23M Buy
13,520
+2,169
+19% +$207K 0.86% 41
2024
Q3
$1.18M Sell
11,351
-1,862
-14% -$190K 0.8% 46
2024
Q2
$1.28M Sell
13,213
-43
-0.3% -$3.97K 0.99% 17
2024
Q1
$1.19M Sell
13,256
-2,088
-14% -$177K 0.86% 25
2023
Q4
$1.22M Buy
+15,344
New +$1.15M 0.87% 27

Other funds holding CL

CastleKeep Investment Advisors's CL Position: Q2 2026 in Review

CastleKeep Investment Advisors reduced its Colgate-Palmolive (CL) stake by 6.7% in Q2 2026, selling an estimated $72.7K and leaving 11,496 shares worth $1.05M. The position accounts for 0.53% of the portfolio, ranked #40.

CastleKeep Investment Advisors first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.28M in Q2 2024. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • CastleKeep Investment Advisors held 11,496 shares of Colgate-Palmolive worth $1.05M as of Q2 2026.
  • CastleKeep Investment Advisors sold 831 Colgate-Palmolive shares in Q2 2026, an estimated $72.7K.
  • Colgate-Palmolive made up 0.53% of CastleKeep Investment Advisors's portfolio in Q2 2026, its #40 holding.
  • CastleKeep Investment Advisors first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • CastleKeep Investment Advisors's Colgate-Palmolive position peaked at $1.28M in Q2 2024.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on CastleKeep Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.